share_log

EF Hutton Reiterates Buy on Mind Medicine, Maintains $21 Price Target

Benzinga ·  Aug 4, 2023 08:13

EF Hutton analyst Elemer Piros reiterates Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $21 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment